ARVN Stock Analysis: Buy, Sell, or Hold?
ARVN - Arvinas, Inc
$9.48
-0.39 (-3.95%)
▼
5d:
-6.97%
30d:
-13.58%
90d:
-19.9%
HOLD
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
ARVN is down 3.8% this week, but smart money is accumulating calls. Top strike: $11 2026-06-18 with 459 OI. Call ratio: 80% View Scanner →
Strength: 4.9/10
Get Alerted When ARVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ARVN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ARVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ARVN is currently trading at $9.48, which is considered oversold relative to its 30-day fair value range of $10.08 to $11.04.
Technical Outlook: Technically, ARVN is in a strong downtrend. Immediate support is located at $9.02, while resistance sits at $11.40. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: ARVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.06 (+52.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARVN is in a strong downtrend. Immediate support is located at $9.02, while resistance sits at $11.40. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: ARVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.06 (+52.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.08 -
$11.04
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding ARVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 52.6% below Wall St target ($15.06)
- CAUTION: 5-day price weakness (-7.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$10.08 -
$11.04
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.02
Resistance Level
$11.40
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.85
Wall Street Target
$15.06
(+52.6%)
Revenue Growth (YoY)
-91.7%
Profit Margin
-247.5%
Share & Embed Analysis
Last updated: May 14, 2026 11:41 AM ET
Data refreshes hourly during market hours. Next update: 12:41 PM
Data refreshes hourly during market hours. Next update: 12:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARVN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Noah Berkowitz
SELL
6435 shares
2026-03-18
Briggs Morrison
BUY
20000 shares
2026-03-06
John G Houston
SELL
35297 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$130 | 54 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 55 HOLD |
Advanced ARVN Option Strategies
Professional options setups generated by AI based on today's ARVN price and gamma walls.